Lactiplantibacillus plantarum ZP-6 mitigates polystyrene nanoplastics-induced liver damage in colitis mice via the gut-liver axis
Frontiers in Microbiology · 13.08.2025 · 16
DOI: 10.3389/fmicb.2025.1626941 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 13.08.2025. Verfasst von Lili Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, Henan Normal University, Xinxiang, China. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Nanoplastics (NPs) have become a ubiquitous environmental pollutant that exhibits a tendency to accumulate in large quantities in the tissues of the host body (enteritis patients) with intestinal damage and poses a serious health risk, for which there is currently no suitable method for in vivo clearance. Studies have found that lactic acid bacteria has the potential to eliminate pollutants from the body.
Methods
In this study, we investigated the capacity of Lactiplantibacillus plantarum ZP-6, a strain isolated from human feces with demonstrated in vitro microplastic-binding activity, to alleviate the physiological toxicity of polystyrene nanoplastics (PS-NPs) in healthy and colitic murine models. Then, we investigated the capacity of Lactiplantibacillus plantarum ZP-6 to alleviate the physiological toxicity of polystyrene nanoplastics (PS-NPs) in healthy and colitic murine models.
Results
Our findings revealed that PS-NPs exposure resulted in systemic accumulation, triggering organ pathology and inflammatory responses in the liver and colon. Dietary intervention with Lactiplantibacillus plantarum ZP-6 significantly reduced PS-NPs retention in blood and tissues while enhancing fecal excretion, restoring hepatic, renal, and colonic histopathology to baseline levels. Mechanistically, ZP-6 downregulated pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) and anti-inflammatory IL-10 in affected tissues. Gut colonization dynamics demonstrated transient enrichment of ZP-6, which facilitated PS-NPs adsorption and fecal clearance. Concurrently, ZP-6 upregulated mucin gene Muc2 and tight junction components ( OCLN , CLDN1 ), reinforcing the intestinal epithelial barrier and impeding PS-NPs translocation. Metabolomic analysis further indicated that ZP-6 rectified PS-NPs-induced hepatic metabolic dysregulation via the gut-liver axis.
Conclusion
These results elucidate a multifaceted probiotic mechanism for NPs detoxification, providing a promising translational strategy to counteract nanoplastic-related health hazards.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Life Sciences, Henan Normal University, Xinxiang, China.
- School of Food Science, Henan Institute of Science and Technology, Xinxiang, China.
- Henan Engineering Laboratory for Bioconversion Technology of Functional Microbes, College of Life Sciences, Henan Normal University, Xinxiang, China.
Zitieren
APA
Zhao, L., Wei, Z., Wang, Y., Chen, W., Zhang, W., Xie, M., Chen, H., Zhang, Y., Gao, H., & Jiang, X. (2025). Lactiplantibacillus plantarum ZP-6 mitigates polystyrene nanoplastics-induced liver damage in colitis mice via the gut-liver axis. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1626941
Vancouver
Zhao L, Wei Z, Wang Y, Chen W, Zhang W, Xie M, et al. Lactiplantibacillus plantarum ZP-6 mitigates polystyrene nanoplastics-induced liver damage in colitis mice via the gut-liver axis. Frontiers in Microbiology. 2025;16. doi:10.3389/fmicb.2025.1626941
BibTeX
@article{Zhao2025,
author = {Zhao, Lili and Wei, Zihan and Wang, Yibin and Chen, Wanrong and Zhang, Wenjing and Xie, Mengfei and Chen, Hong and Zhang, Yiping and Gao, Haiyan and Jiang, Xiaobing},
title = {Lactiplantibacillus plantarum ZP-6 mitigates polystyrene nanoplastics-induced liver damage in colitis mice via the gut-liver axis},
journal = {Frontiers in Microbiology},
year = {2025},
volume = {16},
doi = {10.3389/fmicb.2025.1626941}
}
EUVIMED